Taiwan FDA registration e7f73c40da53bf817696f01337260362
“Abbott” XIENCE Sierra Everolimus Eluting Coronary Stent System
TW: “亞培”賽恩錫拉艾諾莉茉斯冠狀動脈塗藥支架系統
Taiwan·Risk Class 3·MD·ABBOTT VASCULAR·Registered Sep 27, 2018 – Sep 27, 2028ActiveRegistration details
- Analysis ID
- e7f73c40da53bf817696f01337260362
- License Form
- Ministry of Health Medical Device Import No. 031533
- Customs Code
- DHA05603153301
Company information
- Manufacturer
- ABBOTT VASCULAR
- Manufacturer Country
- Ireland
- Authorized Representative
- Abbott Medical Taiwan Co.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular devices
- Product Type (Level 2)
- E0001 Cardiovascular stents
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Sep 27, 2018
- Expiry Date
- Sep 27, 2028
About this record
Access comprehensive regulatory information for “Abbott” XIENCE Sierra Everolimus Eluting Coronary Stent System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number e7f73c40da53bf817696f01337260362 and manufactured by ABBOTT VASCULAR. The authorized representative in Taiwan is Abbott Medical Taiwan Co..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices